This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burke, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burke, B. L., Jr
Related Collections
Right arrow Miscellaneous
Right arrowRelated AAP Red Book topics:
Group A Streptococcal Infections

PEDIATRICS Vol. 109 No. 6 June 2002, pp. 1189

Penicillin Failures?!

To the Editor.—

Kaplan and Johnson, in their article in the November 2001 issue of Pediatrics, claim that oral penicillin V and intramuscular benzathine penicillin G (BPG) have an unacceptably high rate of "microbiologic treatment failures." My problem with their article is that I feel the endpoint, that of "microbiologic treatment failures," is poorly chosen. The correct endpoint should be . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
 CLIN PEDIATRHome page
J. R. Casey
Selecting the Optimal Antibiotic in the Treatment of Group A {beta}-Hemolytic Streptococci Pharyngitis
Clinical Pediatrics, May 1, 2007; 46(4_suppl): 25S - 35S.
[Abstract] [PDF]